Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients

Conclusions: An 8-week regimen of LDV/SOF was well tolerated and efficacious in this treatment-naïve, non-cirrhotic HCV GT4–infected population. This study provides valuable information on a short treatment regimen for HCV GT4 infection in a real-world setting.

Source: The Saudi Journal of Gastroenterology - January 28, 2019 Category: Gastroenterology Authors: Mohammed A Babatin Abdullah S AlGhamdi Abdullah M Assiri Haziz AlBiladi Hammad S AlOthmani Mohammed H Mogharbel Wedad Mahallawi Tarik Asselah Faisal M Sanai Source Type: research